IMS MAXIMS Reveals New Health Record Concept and Unveils Latest Advances

IMS MAXIMSIMS MAXIMS is attending the HC2012 exhibition and conference 2-3 May 2012, where it will reveal a major new research concept and unveil an important upgrade to its MAXIMS ED Module. CEO Shane Tickell will also be among the high-profile speakers included in the conference programme.

By visiting the IMS MAXIMS stand, delegates will be able to discover more about the IMS MAXIMS Da Vinci project. This aims to provide an entirely new approach to electronic patient records that will give patients control of their own data and allow clinicians to access everything they need through mobile aps. The MAXIMS ED module will also be on display. This has been specially designed for A&E departments and the latest upgrade will be demonstrated showing how it enhances its already impressive capabilities.

Shane Tickell, CEO IMS MAXIMS, will be presenting at The Assist National Conference Stream on Wednesday 2nd May, 16:30, Room C. The theme of his presentation is 'Quality & value for Money' in which he will be exploring the importance of developing a partnership approach between suppliers and healthcare provider organisations in order to deliver the best for patients.

IMS MAXIMS will be at stand Stand 31. Delegates are invited to come along to find out more about Da Vinci and the company’s current range of clinical healthcare information systems and how they are 'empowering healthcare providers to deliver better, safer patient care.'

HC2012, organised by The British Computer Society, in association with The Guardian, is targeted at professionals working across health and social care. Its aim is to demonstrate how information and technology is enabling the delivery of more effective health and social care services. It will take place on 2-3 May at the Business Design Centre in Islington, London.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions, IMS MAXIMS currently supports more than 150 organisations, 1.9 million patient records in Ireland and 8 million patient records in the UK, as well as 10,000 users of IMS MAXIMS products.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...